Novozymes A/S

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q2 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.

Novozymes A/S (NVZMF) CEO Ester Baiget on Q2 2020 Results - Earnings Call Transcript

Hidden Stock Market Gems: Novozymes

Novozymes (NVZMF) CEO Ester Baiget on Q1 2020 Results - Earnings Call Transcript

Green Plains

Using biological solutions, exclusive partnership to create functional proteins that provide customers with superior nutritional benefits for animal feeds Using biological solutions, exclusive partnership to create functional proteins that provide customers with superior nutritional benefits for animal feeds

Green Plains and Novozymes Partner in Protein Production

Teradata

As of Nov. 5, shareholders of Novozymes A/S (NVZMY) and Teradata Corporation (NYSE:TDC) have seen their holdings underperforming severely compared to the S&P 500 index over the past several years.

2 Holdings to Reduce Based on Analyst Recommendations

Novozymes A/S (NVZMF) CEO Peder Holk Nielsen on Q3 2019 Results - Earnings Call Transcript

News for Novozymes A/S Stock (NVZMY)